Location: Dallas, TX
CIK: 0002043476 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $135M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NRXP | NRX PHARMACEUTICALS INC | 3,000,000 | $6.39M | 4.7% | $2.07 | 0.0% | COM NEW | 629444209 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 67,500 | $4.925M | 3.7% | $84.00 | 0.0% | COM NEW | 10919W405 |
| FHTX | FOGHORN THERAPEUTICS INC | 102,000 | $488K | 0.4% | $5.69 | 0.0% | COM | 344174107 |
| SLNO | SOLENO THERAPEUTICS INC | 7,500 | $251K | 0.2% | $41.63 | 0.0% | COM | 834203309 |
| REPL | REPLIMUNE GROUP INC | 26,000 | $199K | 0.1% | $7.81 | 0.0% | COM | 76029N106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS INC | 3,207,542 (+30.5%) | $28.9M (-35.5%) | 21.4% | $18.29 | -7.3% | COM | 000899104 |
| PALI | PALISADE BIO INC | 11,414,285 (+153.7%) | $19.97M (+88.9%) | 14.8% | $1.84 | -2.9% | COM | 696389402 |
| SGHT | SIGHT SCIENCES INC | 970,000 (+5.4%) | $3.657M (-49.9%) | 2.7% | $4.16 | +49.2% | COM | 82657M105 |
| ZLAB | ZAI LAB LTD | 450,646 (+12.7%) | $8.477M (+20.1%) | 6.3% | $25.36 | — | ADR | 98887Q104 |
| AURA | AURA BIOSCIENCES INC | 597,576 (+4.4%) | $3.998M (+28.1%) | 3.0% | $8.65 | -37.1% | COM | 05153U107 |
| GPCR | STRUCTURE THERAPEUTICS INC | 127,500 (+41.7%) | $6.146M (-1.8%) | 4.6% | $63.27 | — | SPONSORED ADS | 86366E106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| REPL | REPLIMUNE GROUP INC | 50,000 | $486K | 0.4% | $7.81 | 0.0% | CALL | 76029N106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 7,500 (-62.5%) | $631K (-58.2%) | 0.5% | $43.86 | +64.7% | COM | 03770N101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CLLS | CELLECTIS S A | 3,281,501 | $10.4M | 7.7% | $1.77 | — | SPON ADS | 15117K103 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,800,556 | $8.048M | 6.0% | $2.04 | +133.4% | COM SHS | 877619106 |
| SYRE | SPYRE THERAPEUTICS INC | 100,000 | $5.044M | 3.7% | $23.56 | +46.5% | COM NEW | 00773J202 |
| ORKA | ORUKA THERAPEUTICS INC | 75,000 | $3.679M | 2.7% | $15.19 | +113.6% | COM | 687604108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,500,000 | $5.265M | 3.9% | $7.88 | -66.0% | COM | 462260100 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 175,706 | $4.876M | 3.6% | $13.84 | +106.0% | COM NEW | 045396207 |
| PRAX | PRAXIS PRECISION MEDICINES I | 33,237 | $10.71M | 7.9% | $58.36 | +434.3% | COM NEW | 74006W207 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 135,000 | $2.828M | 2.1% | $37.33 | -37.4% | COM | 90400D108 |